ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erythropoietin Stimulating Agents Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-11V1216
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Erythropoietin Stimulating Agents Market Insights Forecast to 2028
BUY CHAPTERS

Global Erythropoietin Stimulating Agents Market Insights, Forecast to 2030

Code: QYRE-Auto-11V1216
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Biosidus
Biocon Ltd.
Celltrion
Roche
Intas Pharmaceuticals
Teva Pharmaceutical Industries
Thermo Fisher Scientific
Johnson & Johnson

Erythropoietin Stimulating Agents Market Size

The global Erythropoietin Stimulating Agents market is projected to grow from US$ 9779 million in 2024 to US$ 12520 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.

Erythropoietin Stimulating Agents Market

Erythropoietin Stimulating Agents Market

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
Market Analysis and Insights: Global Erythropoietin Stimulating Agents Market
The US & Canada market for Erythropoietin Stimulating Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Erythropoietin Stimulating Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Erythropoietin Stimulating Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Erythropoietin Stimulating Agents include Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson & Johnson and Teva Pharmaceutical Industries, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Erythropoietin Stimulating Agents is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Erythropoietin Stimulating Agents industry development. In 2023, global % revenue of Erythropoietin Stimulating Agents went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Erythropoietin Stimulating Agents market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Erythropoietin Stimulating Agents, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Erythropoietin Stimulating Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Erythropoietin Stimulating Agents revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Erythropoietin Stimulating Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Erythropoietin Stimulating Agents revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Erythropoietin Stimulating Agents Market Report

Report Metric Details
Report Name Erythropoietin Stimulating Agents Market
Accounted market size in 2024 US$ 9779 million
Forecasted market size in 2030 US$ 12520 million
CAGR 4.2
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson & Johnson, Teva Pharmaceutical Industries, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Erythropoietin Stimulating Agents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Erythropoietin Stimulating Agents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erythropoietin Stimulating Agents revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Erythropoietin Stimulating Agents Market growing?

Ans: The Erythropoietin Stimulating Agents Market witnessing a CAGR of 4.2 during the forecast period 2025-2030.

What is the Erythropoietin Stimulating Agents Market size in 2030?

Ans: The Erythropoietin Stimulating Agents Market size in 2030 will be US$ 12520 million.

Who are the main players in the Erythropoietin Stimulating Agents Market report?

Ans: The main players in the Erythropoietin Stimulating Agents Market are Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson & Johnson, Teva Pharmaceutical Industries, Thermo Fisher Scientific

What are the Application segmentation covered in the Erythropoietin Stimulating Agents Market report?

Ans: The Applications covered in the Erythropoietin Stimulating Agents Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Erythropoietin Stimulating Agents Market report?

Ans: The Types covered in the Erythropoietin Stimulating Agents Market report are Epoetin Alfa, Epoetin Beta, Darbepoetin Alfa, Others

Recommended Reports

Erythropoietin Agents

Cell & Gene Therapy

Blood & Hematology Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erythropoietin Stimulating Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Epoetin Alfa
1.2.3 Epoetin Beta
1.2.4 Darbepoetin Alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Erythropoietin Stimulating Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erythropoietin Stimulating Agents Market Perspective (2019-2030)
2.2 Global Erythropoietin Stimulating Agents Growth Trends by Region
2.2.1 Erythropoietin Stimulating Agents Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Erythropoietin Stimulating Agents Historic Market Size by Region (2019-2024)
2.2.3 Erythropoietin Stimulating Agents Forecasted Market Size by Region (2025-2030)
2.3 Erythropoietin Stimulating Agents Market Dynamics
2.3.1 Erythropoietin Stimulating Agents Industry Trends
2.3.2 Erythropoietin Stimulating Agents Market Drivers
2.3.3 Erythropoietin Stimulating Agents Market Challenges
2.3.4 Erythropoietin Stimulating Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Erythropoietin Stimulating Agents by Players
3.1.1 Global Erythropoietin Stimulating Agents Revenue by Players (2019-2024)
3.1.2 Global Erythropoietin Stimulating Agents Revenue Market Share by Players (2019-2024)
3.2 Global Erythropoietin Stimulating Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Erythropoietin Stimulating Agents, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Erythropoietin Stimulating Agents Market Concentration Ratio
3.4.1 Global Erythropoietin Stimulating Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin Stimulating Agents Revenue in 2023
3.5 Global Key Players of Erythropoietin Stimulating Agents Head office and Area Served
3.6 Global Key Players of Erythropoietin Stimulating Agents, Product and Application
3.7 Global Key Players of Erythropoietin Stimulating Agents, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Erythropoietin Stimulating Agents Breakdown Data by Type
4.1 Global Erythropoietin Stimulating Agents Historic Market Size by Type (2019-2024)
4.2 Global Erythropoietin Stimulating Agents Forecasted Market Size by Type (2025-2030)
5 Erythropoietin Stimulating Agents Breakdown Data by Application
5.1 Global Erythropoietin Stimulating Agents Historic Market Size by Application (2019-2024)
5.2 Global Erythropoietin Stimulating Agents Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Erythropoietin Stimulating Agents Market Size (2019-2030)
6.2 North America Erythropoietin Stimulating Agents Market Size by Type
6.2.1 North America Erythropoietin Stimulating Agents Market Size by Type (2019-2024)
6.2.2 North America Erythropoietin Stimulating Agents Market Size by Type (2025-2030)
6.2.3 North America Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
6.3 North America Erythropoietin Stimulating Agents Market Size by Application
6.3.1 North America Erythropoietin Stimulating Agents Market Size by Application (2019-2024)
6.3.2 North America Erythropoietin Stimulating Agents Market Size by Application (2025-2030)
6.3.3 North America Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
6.4 North America Erythropoietin Stimulating Agents Market Size by Country
6.4.1 North America Erythropoietin Stimulating Agents Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Erythropoietin Stimulating Agents Market Size by Country (2019-2024)
6.4.3 North America Erythropoietin Stimulating Agents Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Erythropoietin Stimulating Agents Market Size (2019-2030)
7.2 Europe Erythropoietin Stimulating Agents Market Size by Type
7.2.1 Europe Erythropoietin Stimulating Agents Market Size by Type (2019-2024)
7.2.2 Europe Erythropoietin Stimulating Agents Market Size by Type (2025-2030)
7.2.3 Europe Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
7.3 Europe Erythropoietin Stimulating Agents Market Size by Application
7.3.1 Europe Erythropoietin Stimulating Agents Market Size by Application (2019-2024)
7.3.2 Europe Erythropoietin Stimulating Agents Market Size by Application (2025-2030)
7.3.3 Europe Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
7.4 Europe Erythropoietin Stimulating Agents Market Size by Country
7.4.1 Europe Erythropoietin Stimulating Agents Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Erythropoietin Stimulating Agents Market Size by Country (2019-2024)
7.4.3 Europe Erythropoietin Stimulating Agents Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Erythropoietin Stimulating Agents Market Size (2019-2030)
8.2 China Erythropoietin Stimulating Agents Market Size by Type
8.2.1 China Erythropoietin Stimulating Agents Market Size by Type (2019-2024)
8.2.2 China Erythropoietin Stimulating Agents Market Size by Type (2025-2030)
8.2.3 China Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
8.3 China Erythropoietin Stimulating Agents Market Size by Application
8.3.1 China Erythropoietin Stimulating Agents Market Size by Application (2019-2024)
8.3.2 China Erythropoietin Stimulating Agents Market Size by Application (2025-2030)
8.3.3 China Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Erythropoietin Stimulating Agents Market Size (2019-2030)
9.2 Asia Erythropoietin Stimulating Agents Market Size by Type
9.2.1 Asia Erythropoietin Stimulating Agents Market Size by Type (2019-2024)
9.2.2 Asia Erythropoietin Stimulating Agents Market Size by Type (2025-2030)
9.2.3 Asia Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
9.3 Asia Erythropoietin Stimulating Agents Market Size by Application
9.3.1 Asia Erythropoietin Stimulating Agents Market Size by Application (2019-2024)
9.3.2 Asia Erythropoietin Stimulating Agents Market Size by Application (2025-2030)
9.3.3 Asia Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
9.4 Asia Erythropoietin Stimulating Agents Market Size by Region
9.4.1 Asia Erythropoietin Stimulating Agents Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Erythropoietin Stimulating Agents Market Size by Region (2019-2024)
9.4.3 Asia Erythropoietin Stimulating Agents Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Type
10.2.1 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Application
10.3.1 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Country
10.4.1 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Erythropoietin Stimulating Agents Introduction
11.1.4 Pfizer Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Erythropoietin Stimulating Agents Introduction
11.2.4 Amgen Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.2.5 Amgen Recent Developments
11.3 BioSidus
11.3.1 BioSidus Company Details
11.3.2 BioSidus Business Overview
11.3.3 BioSidus Erythropoietin Stimulating Agents Introduction
11.3.4 BioSidus Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.3.5 BioSidus Recent Developments
11.4 Biocon
11.4.1 Biocon Company Details
11.4.2 Biocon Business Overview
11.4.3 Biocon Erythropoietin Stimulating Agents Introduction
11.4.4 Biocon Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.4.5 Biocon Recent Developments
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Erythropoietin Stimulating Agents Introduction
11.5.4 Celltrion Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.5.5 Celltrion Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Erythropoietin Stimulating Agents Introduction
11.6.4 Roche Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.6.5 Roche Recent Developments
11.7 Intas Pharmaceuticals
11.7.1 Intas Pharmaceuticals Company Details
11.7.2 Intas Pharmaceuticals Business Overview
11.7.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Introduction
11.7.4 Intas Pharmaceuticals Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.7.5 Intas Pharmaceuticals Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Erythropoietin Stimulating Agents Introduction
11.8.4 Johnson & Johnson Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.8.5 Johnson & Johnson Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Erythropoietin Stimulating Agents Introduction
11.10.4 Thermo Fisher Scientific Revenue in Erythropoietin Stimulating Agents Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Pfizer Inc
Amgen Inc
Biosidus
Biocon Ltd.
Celltrion
Roche
Intas Pharmaceuticals
Teva Pharmaceutical Industries
Thermo Fisher Scientific
Johnson & Johnson
List of Tables
    Table 1. Global Erythropoietin Stimulating Agents Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Epoetin Alfa
    Table 3. Key Players of Epoetin Beta
    Table 4. Key Players of Darbepoetin Alfa
    Table 5. Key Players of Others
    Table 6. Global Erythropoietin Stimulating Agents Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Erythropoietin Stimulating Agents Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Erythropoietin Stimulating Agents Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Erythropoietin Stimulating Agents Market Share by Region (2019-2024)
    Table 10. Global Erythropoietin Stimulating Agents Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Erythropoietin Stimulating Agents Market Share by Region (2025-2030)
    Table 12. Erythropoietin Stimulating Agents Market Trends
    Table 13. Erythropoietin Stimulating Agents Market Drivers
    Table 14. Erythropoietin Stimulating Agents Market Challenges
    Table 15. Erythropoietin Stimulating Agents Market Restraints
    Table 16. Global Erythropoietin Stimulating Agents Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Erythropoietin Stimulating Agents Revenue Share by Players (2019-2024)
    Table 18. Global Top Erythropoietin Stimulating Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Stimulating Agents as of 2023)
    Table 19. Global Erythropoietin Stimulating Agents Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Erythropoietin Stimulating Agents Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Erythropoietin Stimulating Agents, Headquarters and Area Served
    Table 22. Global Key Players of Erythropoietin Stimulating Agents, Product and Application
    Table 23. Global Key Players of Erythropoietin Stimulating Agents, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Erythropoietin Stimulating Agents Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Erythropoietin Stimulating Agents Revenue Market Share by Type (2019-2024)
    Table 27. Global Erythropoietin Stimulating Agents Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Erythropoietin Stimulating Agents Revenue Market Share by Type (2025-2030)
    Table 29. Global Erythropoietin Stimulating Agents Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Erythropoietin Stimulating Agents Revenue Share by Application (2019-2024)
    Table 31. Global Erythropoietin Stimulating Agents Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Erythropoietin Stimulating Agents Revenue Share by Application (2025-2030)
    Table 33. North America Erythropoietin Stimulating Agents Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Erythropoietin Stimulating Agents Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Erythropoietin Stimulating Agents Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Erythropoietin Stimulating Agents Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Erythropoietin Stimulating Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Erythropoietin Stimulating Agents Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Erythropoietin Stimulating Agents Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Erythropoietin Stimulating Agents Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Erythropoietin Stimulating Agents Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Erythropoietin Stimulating Agents Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Erythropoietin Stimulating Agents Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Erythropoietin Stimulating Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Erythropoietin Stimulating Agents Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Erythropoietin Stimulating Agents Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Erythropoietin Stimulating Agents Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Erythropoietin Stimulating Agents Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Erythropoietin Stimulating Agents Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Erythropoietin Stimulating Agents Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Erythropoietin Stimulating Agents Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Erythropoietin Stimulating Agents Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Erythropoietin Stimulating Agents Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Erythropoietin Stimulating Agents Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Erythropoietin Stimulating Agents Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Erythropoietin Stimulating Agents Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Erythropoietin Stimulating Agents Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Pfizer Company Details
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Erythropoietin Stimulating Agents Product
    Table 68. Pfizer Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 69. Pfizer Recent Developments
    Table 70. Amgen Company Details
    Table 71. Amgen Business Overview
    Table 72. Amgen Erythropoietin Stimulating Agents Product
    Table 73. Amgen Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 74. Amgen Recent Developments
    Table 75. BioSidus Company Details
    Table 76. BioSidus Business Overview
    Table 77. BioSidus Erythropoietin Stimulating Agents Product
    Table 78. BioSidus Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 79. BioSidus Recent Developments
    Table 80. Biocon Company Details
    Table 81. Biocon Business Overview
    Table 82. Biocon Erythropoietin Stimulating Agents Product
    Table 83. Biocon Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 84. Biocon Recent Developments
    Table 85. Celltrion Company Details
    Table 86. Celltrion Business Overview
    Table 87. Celltrion Erythropoietin Stimulating Agents Product
    Table 88. Celltrion Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 89. Celltrion Recent Developments
    Table 90. Roche Company Details
    Table 91. Roche Business Overview
    Table 92. Roche Erythropoietin Stimulating Agents Product
    Table 93. Roche Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 94. Roche Recent Developments
    Table 95. Intas Pharmaceuticals Company Details
    Table 96. Intas Pharmaceuticals Business Overview
    Table 97. Intas Pharmaceuticals Erythropoietin Stimulating Agents Product
    Table 98. Intas Pharmaceuticals Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 99. Intas Pharmaceuticals Recent Developments
    Table 100. Johnson & Johnson Company Details
    Table 101. Johnson & Johnson Business Overview
    Table 102. Johnson & Johnson Erythropoietin Stimulating Agents Product
    Table 103. Johnson & Johnson Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 104. Johnson & Johnson Recent Developments
    Table 105. Teva Pharmaceutical Industries Company Details
    Table 106. Teva Pharmaceutical Industries Business Overview
    Table 107. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product
    Table 108. Teva Pharmaceutical Industries Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 109. Teva Pharmaceutical Industries Recent Developments
    Table 110. Thermo Fisher Scientific Company Details
    Table 111. Thermo Fisher Scientific Business Overview
    Table 112. Thermo Fisher Scientific Erythropoietin Stimulating Agents Product
    Table 113. Thermo Fisher Scientific Revenue in Erythropoietin Stimulating Agents Business (2019-2024) & (US$ Million)
    Table 114. Thermo Fisher Scientific Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Erythropoietin Stimulating Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Erythropoietin Stimulating Agents Market Share by Type: 2023 VS 2030
    Figure 3. Epoetin Alfa Features
    Figure 4. Epoetin Beta Features
    Figure 5. Darbepoetin Alfa Features
    Figure 6. Others Features
    Figure 7. Global Erythropoietin Stimulating Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Erythropoietin Stimulating Agents Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Others Case Studies
    Figure 12. Erythropoietin Stimulating Agents Report Years Considered
    Figure 13. Global Erythropoietin Stimulating Agents Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Erythropoietin Stimulating Agents Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Erythropoietin Stimulating Agents Market Share by Region: 2023 VS 2030
    Figure 16. Global Erythropoietin Stimulating Agents Market Share by Players in 2023
    Figure 17. Global Top Erythropoietin Stimulating Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Stimulating Agents as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Erythropoietin Stimulating Agents Revenue in 2023
    Figure 19. North America Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
    Figure 21. North America Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
    Figure 22. North America Erythropoietin Stimulating Agents Market Share by Country (2019-2030)
    Figure 23. United States Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Erythropoietin Stimulating Agents Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
    Figure 27. Europe Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
    Figure 28. Europe Erythropoietin Stimulating Agents Market Share by Country (2019-2030)
    Figure 29. Germany Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Erythropoietin Stimulating Agents Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
    Figure 37. China Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
    Figure 38. Asia Erythropoietin Stimulating Agents Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
    Figure 40. Asia Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
    Figure 41. Asia Erythropoietin Stimulating Agents Market Share by Region (2019-2030)
    Figure 42. Japan Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Erythropoietin Stimulating Agents Market Share by Country (2019-2030)
    Figure 52. Brazil Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Erythropoietin Stimulating Agents Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 59. Amgen Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 60. BioSidus Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 61. Biocon Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 62. Celltrion Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 63. Roche Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 64. Intas Pharmaceuticals Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Long acting ESAs Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Market Research Report 2024
Global Erythropoietin EPO Treatment Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Injections Market Research Report 2024
Global Long acting Recombinant Human Erythropoietin Drugs Market Research Report 2024
Global Long acting EPO Drugs Market Research Report 2024
Erythropoietin EPO Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Thrombopoiesis Stimulating Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Erythropoietin Injection Market Research Report 2025
Global Erythroid Maturation Agent Market Research Report 2024
Global Erythropoietin Drugs Market Research Report 2024
Global Erythropoietin Market Insights Forecast to 2030
Epoetin alfa Erythropoietin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epoetin beta Erythropoietin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anemia Treatment Drugs Market Insights Forecast to 2030
Global Recombinant Erythropoietin Drugs Market Insights Forecast to 2030
Global Erythropoietin ELISA Test Kit Market Research Report 2024
Global Darbepoetin Alfa Market Insights Forecast to 2030
Global Short acting Recombinant Human Erythropoietin Injections Market Research Report 2024
Global Short acting Recombinant Human Erythropoietin Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions